
|Videos|March 9, 2015
Improving the Relationship Between Manufacturers and Specialty Pharmacies
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Advertisement
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program
2
New 2025 Hypertension Management Guidelines Include Key Updates
3
Dextromethorphan Emerges as a Novel Antidepressant Pathway for Treatment-Resistant Depression
4
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
5


















